Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension
S. Rich
, B. H. Brundage, P. S. Levy
Medicine, Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
84
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Patient
85%
Pulmonary Hypertension
57%
Combination Therapy
57%
Vasodilator Agent
57%
Survival
57%
Drug
42%
Lung Vascular Resistance
28%
Disease Course
28%
Hydralazine
28%
Clinical Outcome
14%
Proportional Hazards Model
14%
Lung Artery Pressure
14%
Inpatient
14%
INIS
patients
100%
therapy
57%
hypertension
57%
vasodilators
57%
drugs
42%
comparative evaluations
14%
sex
14%
Pharmacology, Toxicology and Pharmaceutical Science
Vasodilator Agent
57%
Pulmonary Hypertension
57%
Survival
57%
Drug
42%
Nifedipine
28%
Hydralazine
28%
Disease Course
28%